Concepedia

Ronald K. Chang

RK

Statistics

Publications

23

Citations

890

H-Index

17

Active since

2003

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Singapore Science Park

Ronald K. Chang is an author at United States Military Academy specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2003–2018

23

Publications

23

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 148 citations · Full text

, , +16

The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque

Jason M. Uslaner, Donnie Eddins, Vanita Puri et al. · Psychopharmacology · 2012 · 72 citations

, , +14

Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M<sub>1</sub> Allosteric Muscarinic Receptor Modulators

Scott D. Kuduk, Ronald K. Chang, Christina N. Di Marco et al. · ACS Medicinal Chemistry Letters · 2010 · 68 citations · Full text

, , +16

Discovery of a Selective Allosteric M<sub>1</sub>Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold

Scott D. Kuduk, Ronald K. Chang, Christina N. Di Marco et al. · Journal of Medicinal Chemistry · 2011 · 62 citations · Full text

, , +17

Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B <sub>1</sub> Receptor Antagonists

Scott D. Kuduk, Christina N. Di Marco, Ronald K. Chang et al. · Journal of Medicinal Chemistry · 2006 · 55 citations · Full text

, , +10

1–5 of 23